Secondary Logo

Journal Logo

July 15th, 2008 - Volume 137 - Issue 2
pp: 233-463


Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain

Webster, Lynn; Jansen, Jan Peter; Peppin, John; More

PAIN. 137(2):428-440, July 15th, 2008.



Show: